UTHR - United Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UTHR is currently covered by 12 analysts with an average price target of $664.32. This is a potential upside of $68.19 (11.44%) from yesterday's end of day stock price of $596.13.

United Therapeutics's activity chart (see below) currently has 394 price targets and 267 ratings on display. The stock rating distribution of UTHR is 70% BUY and 30% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.22% with an average time for these price targets to be met of 262.46 days.

Highest price target for UTHR is $738, Lowest price target is $519, average price target is $664.32.

Most recent stock forecast was given by JESSICA FYE from JPMORGAN. First documented stock forecast 24-Oct-2012.

Best performing analysts who are covering UTHR - United Therapeutics:

Lisa Walter Roanna Ruiz Olivia Brayer Ashwani Verma Liana Moussatos Andreas Argyrides

Currently out of the existing stock ratings of UTHR, 21 are a BUY (70%), 9 are a HOLD (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Sep-2020

$695

$96.28 (16.08%)

$687

Buy Since 26-Sep-2025

$697

$98.28 (16.42%)

$708

11 days ago
(22-Oct-2026)

2/8 (25%)

$112.21 (19.19%)

168

Buy Since 05-Feb-2024

$725

$126.28 (21.09%)

$615

14 days ago
(19-Oct-2026)

2/4 (50%)

$181.85 (33.48%)

108

Hold Since 11-Oct-2024

$566

$-32.72 (-5.46%)

$519

26 days ago
(07-Oct-2026)

17/19 (89.47%)

$21 (3.85%)

236

Hold Since 30-Oct-2025

$738

$139.28 (23.26%)

$575

5 months 26 days ago
(07-May-2026)

2/5 (40%)

$168.82 (29.66%)

93

Show more analysts

Please expand the browser size to see the chart

What is UTHR (United Therapeutics) average time for price targets to be met?

On average it took 262 days for the stock forecasts to be reached, with an average price target met ratio of 84.22%.

Which analyst most recently updated their price target on UTHR (United Therapeutics)?

Jessica Fye

Which analyst has the most public recommendations on UTHR (United Therapeutics)?

Jessica Fye works at JPMORGAN and has 23 price targets and 12 ratings on UTHR

Which analyst is the currently most bullish on UTHR (United Therapeutics)?

Benjamin Burnett with the highest potential upside of $195.34

Which analyst is the currently most reserved on UTHR (United Therapeutics)?

Geoff Meacham with the lowest potential downside of -$518.72
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?